Qnasl and Dymista drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Qnasl (beclomethasone dipropionate) and Dymista (azelastine hydrochloride; fluticasone propionate). Common drug interactions include somnolence among females and upper respiratory tract infection among males.

The phase IV clinical study analyzes what interactions people have when they take Qnasl and Dymista. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Qnasl?

Qnasl has active ingredients of beclomethasone dipropionate. It is often used in allergies. eHealthMe is studying from 1,984 Qnasl users. Check the latest studies of Qnasl.

What is Dymista?

Dymista has active ingredients of azelastine hydrochloride; fluticasone propionate. It is often used in allergies. eHealthMe is studying from 4,407 Dymista users. Check the latest studies of Dymista.

On Jul, 12, 2026

21 people who take Qnasl and Dymista together, and have interactions are studied.

What are the common drug interactions of Qnasl and Dymista, by gender? *:

female:

Somnolence (a state of near-sleep, a strong desire for sleep)
Dizziness
Dry skin
Dysgeusia (disorder of the sense of taste)
Dyspnoea (difficult or laboured respiration)
Erythema (redness of the skin)
Headache (pain in head)
Hypersensitivity
Malaise (a feeling of general discomfort or uneasiness)
Nasal polyps (masses that develop in the lining of the nose)

male:

Upper respiratory tract infection
Chest discomfort
Confusional state
Epistaxis (bleed from the nose)
Hypersensitivity
Incoherent (talking in a confused and unclear way)
Nonspecific reaction (unspecified reaction)
Rash
Sedation
Speech disorder

What are the common drug interactions of Qnasl and Dymista, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Dysgeusia (disorder of the sense of taste)
Oropharyngeal pain
Rash

20-29:

n/a

30-39:

Headache (pain in head)
Hypersensitivity
Restlessness (not able to rest)
Somnolence (a state of near-sleep, a strong desire for sleep)
Weight decreased
Yawning (simultaneous inhalation of air and stretching of the eardrums, followed by exhalation of breath)

40-49:

Dizziness
Malaise (a feeling of general discomfort or uneasiness)
Retching (strong involuntary effort to vomit)
Somnolence (a state of near-sleep, a strong desire for sleep)
Surgery
Therapeutic response unexpected
Urinary tract infection
Vomiting

50-59:

Dyspnoea (difficult or laboured respiration)
Nasal polyps (masses that develop in the lining of the nose)

60+:

Dry skin
Epistaxis (bleed from the nose)
Erythema (redness of the skin)
Nephrolithiasis (calculi in the kidneys)
Pallor
Polyp
Rosacea (a skin condition that causes facial redness)
Tooth extraction

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 38.10%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 28.57%
Asthma: 4 people, 19.05%
Immunodeficiency: 3 people, 14.29%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Qnasl and Dymista?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously